Outcome of Board Meeting Ravinder Heights Limited has submitted to the Exchange, the Audited Financial Results (Standalone & Consolodated) for the period ended March 31, 2026. Ravinder Heights Limited has submitted to the Exchange, the Audited Financial Results (Standalone & Consolodated) for the period ended March 31, 2026.
Outcome of Board Meeting Ravinder Heights Limited has submitted to the Exchange, the Audited Financial Results (Standalone & Consolodated) for the period ended March 31, 2026. Ravinder Heights Limited has submitted to the Exchange, the Audited Financial Results (Standalone & Consolodated) for the period ended March 31, 2026.
Corp. Action Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the company at the Forthcoming Annual General Meeting of the company Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the company at the Forthcoming Annual General Meeting of the company Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the compan
Corp. Action Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the company at the Forthcoming Annual General Meeting of the company Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the company at the Forthcoming Annual General Meeting of the company Recommendation of Final Dividend of Rs. 1.5/- per Equity Shares, subject to the approval of the Shareholders of the compan
Company Update Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026. Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026.
Company Update Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026. Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026.
Company Update Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026. Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026.
Others With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25 With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25
Others With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25 With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25
Others With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25 With respect to the captioned subject, please find attached 37th Annual Report of the company for the financial year 2024-25
Outcome of Board Meeting IL&FS Investment Managers Limited has submitted to the Exchange, the standalone financial results for the period ended March 31, 2026. IL&FS Investment Managers Limited has submitted to the Exchange, the standalone financial results for the period ended March 31, 2026.
Analysts/Institutional Investor Meet/Con. Call Updates Jubilant Ingrevia Limited has informed the Exchange about Transcript Jubilant Ingrevia Limited has informed the Exchange about Transcript Jubilant Ingrevia Limited has informed the Exchange about Transcript Jubilant Ingrevia Limited has informed the Exchange about Transcript
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.